Articles about Johnson & Johnson

American firm Johnson & Johnson's COVID-19 vaccine shots, manufactured in India by Hyderabad-based Biological E, are ready for export, News18 reported.

Around 35 lakh doses of the COVID-19 vaccine developed by United States pharma giant Johnson & Johnson have reportedly reached the apex vaccine testing laboratory in Kasauli, Himachal Pradesh.

The one-dose COVID-19 vaccine developed by American pharma giant Johnson & Johnson and manufactured by the company's local partner, Hyderabad-based Biological E, is likely to be available in India by October, reported News18.

India has approved Johnson & Johnson's single-dose coronavirus vaccine for emergency use, the Union Health Minister Mansukh Mandaviya announced today.

Global healthcare major Johnson & Johnson on Friday said that it has applied for Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine in India.

Johnson & Johnson has withdrawn its proposal seeking an accelerated approval of its COVID-19 vaccine, Janssen, in India, the country's drug regulator said.

US regulators on Monday added a new warning to Johnson & Johnson's COVID-19 vaccine about links to a rare and potentially dangerous neurological reaction but said it's not entirely clear the shot caused the problem.

Johnson & Johnson's one-shot coronavirus vaccine is effective against the highly-contagious Delta variant and provides durable protection against infection overall, the company said in a statement on Thursday.

Johnson & Johnson said on Thursday that US regulators extended the expiration date on its COVID-19 vaccine doses by six weeks.

American pharmaceutical giant Johnson & Johnson has partnered with the Indian firm Biological E. Limited for the production of its COVID-19 vaccine, a move that could boost the country's overall supplies amid a serious shortage.

The United States is considering the production of Johnson & Johnson's COVID-19 vaccine in India along with ways to help manufacturers like the Serum Institute of India (SII) to boost production, Daniel B Smith, Charge d'Affaires of the US Embassy, said on Tuesday.

US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot, after advisers decided its benefits outweigh a rare risk of a blood clot.

US agencies are under pressure to take a call on the resumption of the use of Johnson & Johnson's COVID-19 vaccine.

US healthcare giant Johnson & Johnson said on Tuesday that it has sought approval from India's drug regulator to conduct a bridging clinical study of its single-dose COVID-19 vaccine in the country.

South Africa has joined the US in suspending its roll-out of the Johnson & Johnson COVID-19 vaccine, following reports that six women who received the immunization doses had developed unusual blood clots with low platelet count.

The United States government recommended a "pause" in the administration of the single-dose Johnson & Johnson (J&J) vaccine amid concerns of a "rare and severe type of blood clot."

US pharmaceutical giant Johnson & Johnson is in talks with the Indian government to soon begin clinical trials of its single-shot COVID-19 vaccine in the country, the company said on Friday.

About 15 million doses of Johnson & Johnson's one-shot vaccine have been ruined after a plant in the United States mixed up ingredients, The New York Times has reported.

The United States government on Saturday granted emergency approval to the COVID-19 vaccine developed by Johnson & Johnson, making it the third vaccine available to the public in the US.

Johnson & Johnson's single-dose vaccine offers strong protection against severe COVID-19, according to an analysis released by US regulators that sets the stage for a final decision on a new and easier-to-use shot.

Hyderabad-based pharmaceutical firm Biological E Ltd. is reportedly looking to contract-manufacture 600 million annual doses of the COVID-19 vaccine developed by Johnson & Johnson.

South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.

Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.

Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.

American biotech company Moderna Therapeutics has announced that its COVID-19 vaccine was found to be nearly 95% effective in preventing the novel coronavirus disease.

A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.

Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.

Over the weekend, TikTok won a preliminary injunction against the Trump administration, which prevents the hit video service from getting banned in the US.

Johnson & Johnson's COVID-19 vaccine has shown promise in early-to-mid-stage clinical human trials.

As ByteDance's TikTok deal is likely to see more delays owing to China's pending approval, the video company is moving to prevent itself from getting banned by Trump administration.

In a major development, American pharma giant Johnson & Johnson has launched the final trial of its COVID-19 vaccine.

In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.

In the updates since last night, Fortnite made major headlines.

In the updates since last night, both Facebook and Twitter launched a crackdown on a misleading post from US President Donald Trump.

Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.

The big story in the technology world is: Snap reported its earnings for Q2 2020 with notable gains - 9 million new users and 17% YoY growth in revenue.

With more than 5.3 lakh deaths and 1.14 crore infections, the COVID-19 pandemic continues to grow worse around the world.

Joining the bandwagon of brands that are making their products socially inclusive, the Indian unit of Unilever, Hindustan Unilever, has decided to drop "Fair" from the name of the skincare cream "Fair & Lovely," multiple reports said on Thursday.

American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.

With more than 160,000 deaths and 2.3 million infected cases globally, COVID-19 continues to wreak havoc around the world.